Mitch K. Goldenberg
Directeur Technique/Scientifique/R&D chez CONCERT PHARMACEUTICALS, INC.
Postes actifs de Mitch K. Goldenberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CONCERT PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2008 | - |
Historique de carrière de Mitch K. Goldenberg
Formation de Mitch K. Goldenberg
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Harvard Extension School | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
- Bourse
- Insiders
- Mitch K. Goldenberg
- Expérience
